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Macroautophagy is a cellular catabolic process that involves the sequestration of cyto-
plasmic constituents into double-membrane vesicles known as autophagosomes, which
subsequently fuse with lysosomes, where they deliver their cargo for degradation. The
main physiological role of autophagy is to recycle intracellular components, under condi-
tions of nutrient deprivation, so as to supply cells with vital materials and energy. Selective
autophagy also takes place in nutrient-rich conditions to rid the cell of damaged organelles or
protein aggregates that would otherwise compromise cell viability. Mitophagy is a selec-
tive type of autophagy, whereby damaged or superﬂuous mitochondria are eliminated
to maintain proper mitochondrial numbers and quality control. While mitophagy shares
key regulatory factors with the general macroautophagy pathway, it also involves distinct
steps, speciﬁc for mitochondrial elimination. Recent ﬁndings indicate that parkin and the
phosphatase and tensin homolog-induced putative kinase protein 1 (PINK1), which have
been implicated in the pathogenesis of neurodegenerative diseases such as Parkinson’s
disease, also regulate mitophagy and function to maintain mitochondrial homeostasis.
Here, we survey the molecular mechanisms that govern the process of mitophagy and dis-
cuss its involvement in the onset and progression of neurodegenerative diseases during
aging.
Keywords: aging, autophagy, neuron, mitochondria, mitophagy, neurodegeneration, parkin, PINK1
INTRODUCTION
Macroautophagy (henceforth referred to as autophagy) is a high-
regulated catabolic process responsible for the lysosomal degra-
dation of cytoplasmic constituents. The main characteristic of
the autophagic pathway is the formation of a double-membrane
structure known as autophagosome, which engulfs cytoplasmic
cargo and delivers it to lysosomes for degradation (Klionsky,
2007). In direct correlation with the large variety of autophagy
substrates, including cytoplasmic proteins, ribosomes, organelles,
bacteria and viruses, autophagy defects have been associated
with a wide range of human disorders, such as cancer, autoim-
mune and neurodegenerative diseases (Mizushima et al., 2008).
The main physiological role of autophagy is to supply the cell
with essential materials and energy by recycling intracellular
components, under conditions of nutrient deprivation when
nutrients cannot be obtained from the extracellular environment.
Selective types of autophagy, including pexophagy (Sakai et al.,
2006), ribophagy (Kraft et al., 2008), ER-phagy (Bernales et al.,
2007), protein selective chaperone-mediated autophagy (Cuervo
et al., 2004), nucleophagy (Mijaljica et al., 2010), mitochon-
drial autophagy (mitophagy; Lemasters, 2005) take place under
nutrient-rich conditions to rid the cell of damaged organelles
or protein aggregates that would otherwise compromise cell
viability.
Mitochondria are double-membrane-bound organelles, essen-
tial for energy production and cellular homeostasis in eukaryotic
cells. In addition, mitochondria have vital roles in calcium sig-
naling and storage, metabolite synthesis, and apoptosis (Kroemer
et al., 2007). Thus, mitochondrial biogenesis, as well as, elim-
ination of damaged and superﬂuous mitochondria are highly
regulated processes. Mitophagy is a selective type of autophagy
that mediates the removal of mitochondria. Through mitophagy
cells regulatemitochondrial number in response to theirmetabolic
state and also implement a quality control system for proper elim-
ination of damaged mitochondria. The process of mitophagy is
highly regulated and conserved from yeast to mammals (Table 1).
While mitophagy shares key regulatory factors with the general
autophagy pathway, it also involves distinct steps, speciﬁc for
mitochondrial elimination. Studies in yeast identiﬁed speciﬁc
genes that are required for mitophagy, but not for other types
of autophagy (Kanki et al., 2009a; Kanki and Klionsky, 2010),
demonstrating the selective regulation of this process. Despite the
fact that the actual selection of mitochondria for degradation is a
still obscure part of the process, recent studies shed light on the
mechanisms that governmitophagy and regulate removal of mito-
chondria during developmental processes or upon mitochondrial
damage. In this review, we survey the molecular mechanisms that
mediate mitophagy and also highlight how defects in this process
may contribute to the onset and progression of neurodegenerative
diseases during aging.
MOLECULAR MECHANISMS OF MITOPHAGY
The molecular mechanisms of mitophagy were studied in the
yeast Saccharomyces cerevisiae. The yeast uth1 gene encodes a
Sad1p/UNC-84 (SUN)-domain protein that is located in the
outer mitochondrial membrane and is essential for the speciﬁc
autophagic elimination of mitochondria upon nitrogen starvation
or rapamycin treatment, without inﬂuencing general autophagy
(Kissova et al., 2004). The protein Aup1, a member of pro-
tein phosphatase 2C (PP2C) superfamily that is located in the
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Atg32 – – – Mitophagy receptor Interaction with Atg8 recruits the
autophagic machinery
– DCT-1 – NIX/BNIP3 Mitophagy receptor Interaction with LC3/GABARAP
recruits the autophagic machinery
– PINK-1 Pink1 PINK1 Ser/Thr protein kinase Phosphorylates and recruits Parkin
to mitochondria
– PDR-1 Parkin PARKIN E3 ubiquitin ligase Ubiquitinates outer membrane
mitochondrial proteins such as
Mfn1/2, VDAC, MIRO1/2
– SQST-1 (T12G3.1) Ref(2)P SQST-
1/p62
Adaptor protein Interacts with ubiquitinated proteins
to recruit the autophagic machinery
Fzo1 FZO-1 Fzo, Dmfn MFN-1/2 Outer membrane fusion Ubiquitinated by Parkin; their
degradation precedes mitophagy
induction
Vdac1 VDAC-1 (R05G6.7) DmVDAC VDAC1 Voltage-dependent anion channel;
outer mitochondrial membrane
Upon ubiquitination by Parkin
induces the recruitment of the
autophagic machinery
mitochondrial intermembrane space, is essential for efﬁcient
mitophagy at the stationary phase (Tal et al., 2007). Aup1 may
regulate mitophagy by also controlling the retrograde response
pathway (Journo et al., 2009).
Another factor required for mitophagy is Atg32, a 59 kDa
protein, located in the outer mitochondrial membrane (Kanki
et al., 2009b; Okamoto et al., 2009a). The amino- and carboxy-
terminal domains of Atg32 are oriented toward the cytoplasm and
intermembrane space, respectively. Atg32 is thought to act as a
mitochondrial receptor that binds the adaptor protein Atg11, to
sequester mitochondria to the phagophore assembly site (PAS),
during mitophagy (Okamoto et al., 2009b). The cytosolic domain
of Atg32 contains an evolutionary conserved WXXL-like motif,
which is critical for the interaction with Atg8 (the yeast homolog
of the mammalian autophagosome protein LC3; Okamoto et al.,
2009b). Thus, Atg32 can interact with Atg8 directly through
the WXXL-like motif or indirectly through Atg11. This asso-
ciation is thought to recruit autophagosomes to mitochondria
(Figure 1A). Atg32 is the ﬁrst protein shown to interact with
the core autophagic machinery, and be required speciﬁcally for
mitophagy. Interestingly, loss of Atg32 does not alter cellular reac-
tive oxygen species (ROS) levels or growth on non-fermentable
carbon sources (Kanki et al., 2009b). This suggests the existence of
additional Atg32-independent mitophagy pathways. Recent stud-
ies identiﬁed twomitogen-activatedprotein kinases (MAPKs), Stl2
and Hog1, also required for the speciﬁc elimination of mitochon-
dria via autophagy in S. cerevisiae (Mao et al., 2011). These two
positive regulators establish an additional regulatory step in the
process of mitophagy, underlining the complexity of this organelle
quality control system.
THE PINK1/PARKIN PATHWAY IN MITOPHAGY REGULATION
Mutations in the genes encoding the cytosolic E3 ubiquitin ligase
Parkin and the mitochondrial phosphatase and tensin homolog
(PTEN)-induced kinase 1 (PINK1) have been shown to cause
a recessive form of parkinsonism (Kitada et al., 1998; Valente
et al., 2004). However, the involvement of these proteins in the
pathogenesis of Parkinson’s disease remained obscure. Studies
in Drosophila melanogaster indicate that PINK1 and Parkin act
in the same genetic pathway to regulate mitochondrial network
integrity (Greene et al., 2003; Park et al., 2006). In healthy mito-
chondria, PINK1 is probably imported through the translocase
complexes of the outer and innermitochondrialmembrane (TOM
and TIM, respectively). PINK1 is subsequently cleaved by several
proteases such as the mitochondrial-processing protease (MPP),
the inner membrane presenilin-associated rhomboid-like pro-
tease (PARL; Meissner et al., 2011; Greene et al., 2012). Upon
mitochondrial depolarization, import of PINK1 to the innermito-
chondrial membrane is blocked and PINK1 is stabilized on outer
mitochondrial membrane (Lazarou et al., 2012). Accumulation
of PINK1 on the mitochondrial surface induces mitophagy by
recruiting Parkin to damaged mitochondria through a mecha-
nism that is not well-understood. Thus, PINK1 likely functions
as a sensor for damaged mitochondria. Recent studies have
demonstrated that translocation of Parkin to impaired mitochon-
dria requires PINK1 activity (Narendra et al., 2008; Geisler et al.,
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FIGURE 1 | Mechanisms and roles of mitophagy. (A) In yeast Atg32 (blue),
a mitochondrial outer membrane protein, interacts with Atg8 (red) directly or
indirectly through the adaptor protein Atg11 (green), and links mitochondria
to autophagic machinery. (B) During red blood cell development the
mitochondrial population is eliminated by mitophagy. Nix (blue), an outer
mitochondrial membrane protein, serves as a receptor for targeting
mitochondria to autophagosomes through its interaction with the
autophagosomal protein LC3 (red). (C) In the fertilized C. elegans embryo,
the autophagic pathway selectively degrades sperm-derived mitochondria
(blue; oocyte-derived mitochondria are shown in pink). (D) Upon mitochondrial
depolarization, PINK1 (green) is stabilized on the outer mitochondrial
membrane. Subsequently, Parkin (blue) is recruited and ubiquitylates outer
mitochondrial membrane proteins such as MFN1/2 and VDAC1. (1)
Ubiquitinated MFN1/2 is degraded by the proteasome system. Damaged
mitochondria are isolated and cannot fuse with the healthy mitochondrial
population. (2) Next, ubiquitin-binding adaptor molecules, such as p62 (black),
are recruited to mitochondria to initiate mitophagy through their interaction
with LC3 (red).
2010; Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza
et al., 2010). Following translocation, Parkin ubiquitylates outer
mitochondrial membrane proteins. Subsequently other adaptor
molecules, such as p62, are recruited to mitochondria to initi-
ate mitophagy (Figure 1D). The mitochondrial fusion proteins
mitofusin 1 and 2 have been identiﬁed as substrates of Parkin
(Gegg et al., 2010; Poole et al., 2010; Tanaka et al., 2010; Rakovic
et al., 2011). Parkin prevents mitochondrial fusion through
degradation of mitofusins, thereby isolating impaired mitochon-
dria from the healthy mitochondrial population. Apart from
www.frontiersin.org December 2012 | Volume 3 | Article 297 | 3
“fgene-03-00297” — 2012/12/17 — 21:59 — page 4 — #4
Palikaras andTavernarakis Mitophagy in health and disease
mitofusins, overexpression of Parkin also mediates the ubiqui-
tination of other outer mitochondrial membrane proteins, such as
the voltage-dependent anion channel (VDAC), the mitochondrial
RhoGTPases (MIRO) 1 and 2, aswell as components of mitochon-
drial translocase complex (TOM70, TOM40, and TOM20; Chan
et al., 2011; Yoshii et al., 2011). However, the relevance of these
substrates to the induction of mitophagy in vivo remains to be
investigated.
THE ROLE OF MITOPHAGY IN DEVELOPMENT
Certain developmental processes entail removal of non-damaged
mitochondria, a process that is essential for successful organ
and tissue development. During erythrocyte differentiation,
mitophagy eliminates healthy mitochondria in programmed fash-
ion. Erythrocytes transfer oxygen form the lungs to peripheral
tissues and are characterized by lack of internal organelles, includ-
ing mitochondria, an adaptation that perhaps serves to increase
their oxygen carrying capacity. Recently, Nix was identiﬁed as a
protein thatmediates elimination of mitochondria in reticulocytes
(immature red blood cells; Schweers et al., 2007; Sandoval et al.,
2008). Nix is a Bcl2-related protein with an atypical BH3 domain
that is localized to outer mitochondrial membrane and is required
for the elimination of reticulocyte mitochondria. Nix−/− mice
retain mitochondria in erythrocytes and develop anemia because
of decreased survival of these cells (Schweers et al., 2007; Sandoval
et al., 2008). Studies of erythrocyte differentiation suggest that
Nix is not required for induction of mitophagy per se, but for the
engulfment of mitochondria by autophagosomes. Nix contains
a cytoplasmic WXXL-like motif, which interacts with LC3 (the
mammalian homolog of the yeast Atg8) and the GABA receptor-
associated protein (GABARAP) in vivo and in vitro (Schwarten
et al., 2009; Novak et al., 2010). Therefore, Nix appears to act as a
receptor for targeting autophagosomes to mitochondria in a man-
ner similar to the yeast Atg32 (Figure 1B). Nevertheless, despite
the requirement of Nix in erythrocyte differentiation, treatment
of reticulocytes with uncoupling agents induces mitophagy upon
mitochondrial depolarization in aNix-independentmanner (San-
doval et al., 2008). The mechanisms mediating Nix-independent
mitophagy in reticulocytes remain unclear.
An additional important developmental role for mitophagy is
the removal of paternal mitochondria in fertilized oocytes (Al
Rawi et al., 2011; Sato and Sato, 2011). Although, sperm contains
mitochondria, which are transferred to the oocyte upon fertiliza-
tion, only maternal mitochondrial DNA (mtDNA) is ultimately
inherited. Two studies in Caenorhabditis elegans revealed that
the autophagic pathway selectively degrades sperm mitochondria
during the early stages of embryogenesis (Figure 1C). How-
ever, the signal that activates mitophagy, to selectively eliminate
sperm-derived mitochondria remains unknown.
MITOPHAGY IN NEURODEGENERATION
Neuronal cells typically require increased numbers of mitochon-
dria, since most neuronal ATP is generated through oxidative
phosphorylation. This high-energy demand is dictated by numer-
ous neuronal processes, such as axonal transport of macro-
molecules and organelles, maintenance of membrane potential,
loading and releasing neurotransmitters, and buffering cytosolic
calcium. Therefore, neuronal survival and activity are critically
dependent on mitochondrial integrity and functionality (Rugarli
and Langer, 2012). Mitochondria are highly dynamic organelles
that constantly move and undergo frequent ﬁssion and fusion
events. Several components of the ﬁssion/fusion machinery have
been linked to various neurological diseases, underlying the sig-
niﬁcance of mitochondrial dynamics in neuronal homeostasis
(Alexander et al., 2000; Zuchner et al., 2004; Waterham et al.,
2007). Recent studies have shown that ﬁssion/fusion dynamics not
only sort out damagedmitochondrial components by distributing
them throughout the mitochondrial network, but also fragment
and isolate defectivemitochondria prior tomitophagy (Twig et al.,
2008a,b). The interplay between mitochondrial dynamics and
mitophagy is further underscored by the fact that excessive fusion
prevents autophagic mitochondrial degradation (Twig and Shiri-
hai, 2011). Indeed, increased fusion protects mitochondria from
massive degradation by starvation-induced autophagy (Rambold
et al., 2011). Therefore, modulation of mitochondrial dynam-
ics, to increase ﬁssion or decrease fusion, facilitates isolation
of damaged mitochondria and their subsequent elimination by
mitophagy. Hence, mitochondrial damage and deregulation of
mitophagyhas been implicated in theonset andprogressionof sev-
eral age-associated neurodegenerative diseases, such as Parkinson’s
(Schapira, 2011), Alzheimer’s, and Huntington disease (Batlevi
and La Spada, 2011).
PARKINSON’S DISEASE
Parkinson’s disease is caused by loss of dopaminergic neurons
in the substantia nigra, a region important for motor control
and coordination. Loss-of-function mutations in PINK1 and/or
PARK2 genes have been linked with the early onset of hered-
itary forms of Parkinson’s disease. The PINK1/Parkin pathway
has been shown to regulate the elimination of damaged mito-
chondria through mitophagy (Narendra et al., 2008, 2010). In
addition, mtDNA mutations and/or deletions are more frequent
in patients with Parkinson’s disease compared to age-matched
individuals in the population (Bender et al., 2006). Such muta-
tions and/or deletions commonly appear and accumulate during
aging inmitochondria of the substantia nigra neurons (Kraytsberg
et al., 2006). Consistently, loss of dopaminergic neurons in the
substantia nigra that leads to the development of Parkinson’s dis-
ease correlates with mitochondrial damage accumulation in these
neurons. Thus, excessive mitochondrial stress upon exposure to
environmental toxins or defects in mtDNA, and the inability of
the cell to eliminate damaged mitochondria through mitophagy,
may contribute to Parkinson’s disease pathogenesis (Ethell and
Fei, 2009). However, mitophagy pathways have been character-
ized in non-neuronal cells, with neuronal mitophagy remaining
a relatively obscure process. Some reports suggest that mito-
chondrial depolarization and respiratory deﬁciency do not induce
Parkin recruitment in neurons (Sterky et al., 2011; Van Laar et al.,
2011). Other studies in neuronal cells indicate that Parkin is
recruited to depolarized mitochondria and mediates mitochon-
drial elimination by mitophagy in a Parkin-dependent manner
(Wang et al., 2011; Cai et al., 2012). Thus, although mutations in
PINK1 and Parkin have been associated with neurodegeneration
in Parkinson’s disease, further work is needed to clarify if the
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PINK1/Parkin pathway regulates damage-induced mitophagy in
neurons.
ALZHEIMER’S DISEASE
Alzheimer’s disease is the most common age-associated neurode-
generative disorder, characterized by cognitive dysfunction and
loss of memory, caused by neuronal cell death in cerebral cor-
tex. Tissue sections from Alzheimer’s disease patient brains show
distinctive intracellular neuroﬁbrillary tangles and extracellular
amyloid plaques composed of beta-amyloid derived from amy-
loid precursor protein (APP). While, the predominant hypothesis
is that excess beta-amyloid leads to neuronal death, the mecha-
nism that underlies pathogenesis is still unclear. Mitochondrial
damage has been implicated in the development and progres-
sion of Alzheimer’s disease, since abnormalities in mitochondrial
structure have been observed in afﬂicted individuals (Baloyan-
nis, 2006). Moreover, beta-amyloid fragments have been found to
localize and accumulate within mitochondria (Casley et al., 2002;
Lustbader et al., 2004). In addition, the presence of autophagic
vacuoles in neurons of Alzheimer’s disease patients further impli-
cates cytoplasmic and organelle-speciﬁc degradation in disease
progression (Boland et al., 2008). In this context, mitophagy may
have pivotal role in ameliorating, or defending against the devel-
opment of Alzheimer’s disease through elimination of defective
mitochondria, carrying cytotoxic beta-amyloid fragments.
HUNTINGTON’S DISEASE
Huntington’s disease is an autosomal dominant neurodegenerative
disease caused by the abnormal expansion of the cytosine, adenine,
and guanine (CAG) repeats within huntingtin (Htt) gene. The
severity of pathology correlates with the number of CAG repeats,
the length of expansion (Costa and Scorrano, 2012). Hunting-
ton’s disease is characterized by progressive motor dysfunction,
as well as psychiatric and cognitive abnormalities caused by loss
of cortical and striatal neurons (Purdon et al., 1994). Expres-
sion of mutant Htt is associated with mitochondrial dysfunction
both in patients and mouse models of Huntington’s disease.
Decreased mitochondrial membrane potential, defects in mito-
chondrial calciumuptake, decreased respiratory function, reduced
mitochondrial mobility and changes in mitochondrial structure
are some of the observed mitochondrial defects in Hunting-
ton’s disease patients (Bossy-Wetzel et al., 2008). Additionally, the
peroxisome proliferator-activated receptor gamma coactivator-1a
(PGC-1a), the master regulator of mitochondrial biogenesis, has
been linked to metabolic and transcriptional defects in Hunting-
ton’s disease (Weydt et al., 2006). Mitophagymay serve a protective
function against neuronal loss in Huntington’s disease by elimi-
nating damagedmitochondria. Consistent with this notion, recent
ﬁndings indicate that Huntington’s disease pathology is associated
with autophagic cargo recognition defects that lead to accumu-
lation of damaged mitochondria in cytoplasm (Martinez-Vicente
et al., 2010).
MITOPHAGY IN AGING
Mitochondrial dysfunction has already been correlatedwith aging.
Mitochondria are the primary source of ROS, such as nitrox-
ides, hydrogen peroxide, and superoxide anions (Hekimi et al.,
2011; Sena and Chandel, 2012). Aging particularly affects mito-
chondrial homeostasis, as ROS generation in mitochondria leads
to mitochondrial protein and mtDNA damage. mtDNA is more
sensitive and susceptible to oxidative damage due to lack of
histones. mtDNA repair mechanisms are also less efﬁcient or
robust, compared to nuclear DNA. Accordingly, inhibition or
abnormal synthesis of mitochondrial proteins exacerbates mito-
chondrial dysfunction. mtDNA mutations accumulate during
aging, an event that has been correlated with age-related decreased
autophagic activity (Cuervo, 2008; Hubbard et al., 2012). Inmam-
mals, morphological and enzymatic mitochondrial defects occur
during aging (Navarro and Boveris, 2004). Therefore, it is pos-
sible that accumulation of damaged mitochondria could induce
mitophagy to preserve cellular homeostasis. Studies in yeast have
shown that deletion of themitochondrial membrane proteinUth1
results in a selective defect in mitophagy and decreased lifespan
upon nutrient deprivation (Kissova et al., 2004). Caloric restric-
tion is known to promote longevity from yeast tomammals. Given
that caloric restriction induces autophagy, increased longevity
may in part originate from enhanced elimination of dysfunctional
mitochondria (Yen and Klionsky, 2008). Further studies should
clarify whether mitophagy is indeed involved in mediating part of
the effects of caloric restriction on lifespan.
CONCLUDING REMARKS
Although ﬁndings in diverse organisms indicate that the pro-
cess of mitophagy requires the core autophagic machinery of
cell, the initial signals that trigger and activate this selective type
of autophagy, remain obscure. These signals appear to differ
according to nutrient conditions, developmental processes, and
damage-induced mitochondrial loss. Despite the fact that several
proteins, such as ATG32, Nix, PINK1, Parkin have been identiﬁed
as being critical for targeting mitochondria to autophagosomes,
important information about the recruitment of these proteins
to mitochondria and their interaction with the core autophagic
machinery is lacking. Further investigation of the mechanisms
mediating mitophagy will elucidate these key steps and shed light
onto the link between mitophagy and aging. As a corollary, these
studies are also likely to provide novel potential targets for ther-
apeutic interventions against age-associated pathologies such as
neurodegenerative disorders.
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